| BNP PARIBAS US GROWTH PRIVILEGE USD CAP | RVI USA CRECIMIENTO | 11,10% | 84,87% | 66,24% | 358,24% |
| JPM JAPAN EQUITY C (ACC) USD (HEDGED) | RVI JAPÓN | 18,41% | 111,90% | 111,01% | 358,21% |
| CHALLENGE TECHNOLOGY OPPORTUNITIES S-A | RVI TECNOLOGÍA | 19,89% | 119,03% | 73,53% | 354,05% |
| JPM TAIWAN C (DIST) USD | RVI CHINA | 76,82% | 184,81% | 133,93% | 353,59% |
| UBS (LUX) EQUITY SICAV - USA GROWTH (USD) Q-ACC | RVI USA CRECIMIENTO | 5,13% | 79,77% | 61,05% | 352,41% |
| PICTET - ROBOTICS HI EUR | RVI TECNOLOGÍA | 21,38% | 124,74% | 71,34% | 352,36% |
| PRIVILEDGE - ALPHA JAPAN (CHF) M CAP SYST. HDG | RVI JAPÓN | 18,08% | 98,05% | 144,22% | 351,64% |
| JPM US GROWTH C (ACC) EUR (HEDGED) | RVI USA CRECIMIENTO | -5,57% | 74,60% | 43,74% | 350,03% |
| JPM TAIWAN A (DIST) USD | RVI CHINA | 76,26% | 182,93% | 132,58% | 349,89% |
| JPM TAIWAN D (ACC) USD | RVI CHINA | 74,62% | 179,21% | 132,17% | 349,79% |
| BANKINTER EE.UU. NASDAQ 100, FI R | RVI TECNOLOGÍA | 8,46% | 86,55% | 56,03% | 347,29% |
| MAN JAPAN COREALPHA EQUITY I H CHF | RVI JAPÓN | 31,73% | 108,08% | 242,99% | 347,08% |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 21,98% | 108,29% | 78,80% | 345,50% |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 21,92% | 108,42% | 77,58% | 344,32% |
| LORD ABBETT INNOVATION GROWTH FUND Z USD CAP | RVI GLOBAL CRECIMIENTO | -1,26% | 93,88% | 35,56% | 344,26% |
| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | RVI BIOTECNOLOGÍA | 21,74% | 107,97% | 77,54% | 343,79% |
| AB SICAV I-AMERICAN GROWTH PORTFOLIO S1 EUR | RVI USA CRECIMIENTO | 6,17% | 65,28% | 54,70% | 343,29% |
| AB SICAV I-AMERICAN GROWTH PORTFOLIO S1 USD | RVI USA CRECIMIENTO | 6,81% | 65,31% | 55,90% | 342,08% |
| GOLDMAN SACHS JAPAN EQUITY PORTFOLIO I H USD CAP | RVI JAPÓN | 27,35% | 91,36% | 141,23% | 341,95% |
| UBS (LUX) EQUITY FUND - TECH OPPORTUNITY (USD) (CHF HEDGED) Q-ACC | RVI TECNOLOGÍA | 6,58% | 91,91% | 49,89% | 341,31% |
